| 1 |
Tim Forshew |
Inivata |
4 |
| 2 |
Jaroslaw Michal Szary |
Ossianix |
3 |
| 3 |
George Stuart Cockerill |
Smithkline Beecham Limited |
2 |
| 3 |
Beatriz Goyenechea Corzo |
Cancer Research Technology Limited |
2 |
| 3 |
Pascal Merchiers |
Cancer Research Technology Limited |
2 |
| 3 |
Miquel Costa Ferrando |
— |
2 |
| 3 |
Josephine Salimu |
Cancer Research Technology Limited |
2 |
| 3 |
Nina Eissler |
Black Belt Therapeutics Limited |
2 |
| 3 |
Simone Filosto |
Black Belt Therapeutics Limited |
2 |
| 3 |
Kevin Moulder |
Cancer Research Technology Limited |
2 |
| 3 |
David Horna Tomas |
Institut Quimic De Sarria Cets Fundacio Privada |
2 |
| 3 |
Anne Goubier |
Cancer Research Technology Limited |
2 |
| 3 |
James Good |
Pfizer |
2 |
| #14 |
Gary Stafford |
Global Invacom Limited |
1 |
| #14 |
Nigel Richardson |
Nokia |
1 |
| #14 |
Adrian Maddocks |
Global Invacom Limited |
1 |
| #14 |
Hans Jakob Kristoffer Famm |
Galvani Bioelectronics Limited |
1 |
| #14 |
Arun Sridhar |
Galvani Bioelectronics Limited |
1 |
| #14 |
Sarah Davies |
Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin |
1 |
| #14 |
Mary Kerr |
Kandy Therapeutics Limited |
1 |
| #14 |
Mike Trower |
Kandy Therapeutics Limited |
1 |
| #14 |
Matthew Barrett |
Reviral Limited |
1 |
| #14 |
Markus Schober |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #14 |
Christopher B. J. Groombridge |
Kindeva Drug Delivery |
1 |
| #14 |
Gabor Pap |
GE |
1 |
| #14 |
Graham David Moores |
Endura Spa |
1 |
| #14 |
Kexuan SUN |
Viavi Solutions |
1 |
| #14 |
Philip G. Humphreys |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #14 |
John Carroll |
Airbus Defence And Space Gmbh |
1 |
| #14 |
Agostino Marasco |
Autifony Therapeutics Limited |
1 |
| #14 |
Giuseppe Alvaro |
Autifony Therapeutics Limited |
1 |
| #14 |
Elie Allouis |
Airbus Defence And Space Gmbh |
1 |